Effects of Aescusan on Fibrinolytic Plasma Activity in Patients with  Hypothyroidism

Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/1722

Full metadata record

DC Field	Value	Language
dc.contributor.author	Olenovych, Olha	-
dc.date.accessioned	2012-06-11T12:34:18Z	-
dc.date.available	2012-06-11T12:34:18Z	-
dc.date.issued	2012	-
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/1722	-
dc.description.abstract	The administration of Aescusan into the complex treatment program of patients with hypothyroidism was found to increase total plasma fibrinolysis almost to the control level, normalize the intensity of non-enzymatic fibrinolysis, considerably elevate the enzymatic lysis of fibrine and more effectively, as compared with standard treatment program, restore normal structure of plasma fibrinolysis.	ru_RU
dc.publisher	Pharmaceutical Crops	ru_RU
dc.subject	Aescusan	ru_RU
dc.subject	hypothyroidism	ru_RU
dc.subject	fibrinolytic activity	ru_RU
dc.subject	plasma fibrinolysis	ru_RU
dc.subject	ескузан	ru_RU
dc.subject	гіпотиреоз	ru_RU
dc.subject	фібринолітична активність	ru_RU
dc.subject	плазмовий фібриноліз	ru_RU
dc.subject	эскузан	ru_RU
dc.subject	гипотиреоз	ru_RU
dc.subject	фибринолитическая активность	ru_RU
dc.subject	плазменный фибринолиз	ru_RU
dc.title	Effects of Aescusan on Fibrinolytic Plasma Activity in Patients with Hypothyroidism	ru_RU
dc.type	Article	ru_RU
Appears in Collections:	Статті. Кафедра клінічної імунології, алергології та ендокринології

Files in This Item:

There are no files associated with this item.

DSpace JSPUI